PFIZER INC Q1 2025 Filing

Filed May 13, 2025

Portfolio Value

$500.8B

Holdings

21

Report Date

Q1 2025

Filing Type

13F-HR

All Holdings (21 positions)

#StockSharesValue% PortfolioType
1
BNTXBIONTECH SE
3,658,361$333.1B66.51%
2
ALLOALLOGENE THERAPEUTICS INC
22,032,040$32.2B6.42%
3
ORICORIC PHARMACEUTICALS INC
5,376,344$30.0B5.99%
4
ARVNARVINAS INC
3,457,815$24.3B4.85%
5
TRMLTOURMALINE BIO INC
1,272,214$19.4B3.86%
6
WVEWAVE LIFE SCIENCES LTD
1,875,000$15.2B3.02%
7
BHVNBIOHAVEN LTD
505,645$12.2B2.43%
8
CRDFCARDIFF ONCOLOGY INC
2,411,575$7.6B1.51%
9
PYXSPYXIS ONCOLOGY INC
7,032,770$6.9B1.38%
10
CRBUCARIBOU BIOSCIENCES INC
4,690,431$4.3B0.86%
11
ZURAZURA BIO LTD
2,970,022$3.8B0.76%
12
CELCCELCUITY INC
349,406$3.5B0.71%
13
EPIEURESSA PHARMA INC
1,675,000$2.6B0.53%
14
SPROSPERO THERAPEUTICS INC
2,362,348$1.7B0.34%
15
ZNTLZENTALIS PHARMACEUTICALS INC
953,834$1.5B0.30%
16
ANTXAN2 THERAPEUTICS INC
715,295$972.8M0.19%
17
NXTCNEXTCURE INC
1,891,763$908.6M0.18%
18
QTTBQ32 BIO INC
277,777$458.3M0.09%
19
BOLT1EURBOLT BIOTHERAPEUTICS INC
626,109$250.4M0.05%
20
SENS1GBPSENSEONICS HLDGS INC
43,426$28.5M0.01%
21
DNAGINKGO BIOWORKS HOLDINGS INC
2,928$16.7M0.00%